Capital Fund Management S.A. Bio Techne Corp Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $728,810 - $965,199	10,794 New	10,794 $734,000
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $7.22 Million - $9.43 Million	-22,945 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $5.67 Million - $7.39 Million	22,945 New	22,945 $7.29 Million
Q2 2019 Aug 12, 2019	SELL	$188.72 - $215.43 $509,544 - $581,661	-2,700 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$136.09 - $200.44 $367,443 - $541,188	2,700 New	2,700 $536,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.